The trial

Study of a new compound that is being developed for the treatment of inflammatory diseases.

Requested participants

M/F, Healthy, 18 - 64 years old, non-smokers only.

Particulars

  • Your body weight must be at least 50 kg and your Body Mass Index (BMI) is between 18.5 and 30.0 kg/m2. The BMI shows the relation between body weight in kilograms and height in meters.
  • As a male you are only allowed to participate in this study if you use sufficient contraception measures (a condom in combination with a female contraception method) or if you are surgically sterilized. 
  • As a female you are only allowed to participate in this study if you use sufficient contraception measures (a condom in combination with a female contraception method) , or if you are surgically sterilized or if you are postmenopausal for at least 1 year. 
  • To determine if you are suitable to participate in this study, you will undergo a medical screening. 

Period

The study consists of 4 parts. You can only participate in 1 of the parts in this study.

Part A consists of 1 period during which you will stay in our research facility in Groningen for 4 days (3 nights).

Group 4 days stay
Group A3 22 April - 25 April 2019

Finally, for all parts there will be a follow-up visit 7 to 10 days after the (last) administration.

Please note: You have to be available for all dates for the group of choice to be able to participate in this study. The actual dates will be published on our website. These are the currently planned dates; however, these may be subject to change.

Compensation

You will receive a gross compensation of €567.- for participation in one of the groups of part A of this study.

Travelling expenses will be reimbursed based on the distance traveled (€0.19 net per kilometer) with a minimum of €12.- and a maximum of €160.- (840 kilometers) per return, regardless of the mode of transportation.